Comparing migraine prevention drugs: atogepant, propranolol, topiramate
Treatments studied
Part of Brain & nervous system clinical trials.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had migraines for at least 12 months, starting before age 50.
- You have at least 4 moderate to severe headache days per month (confirmed by a headache diary).
- You have not taken atogepant, propranolol, or topiramate before (or are willing to stop them).
- You are not pregnant or breastfeeding, and agree to use birth control if needed.
- You do not have certain rare migraine types (like hemiplegic migraine) or epilepsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different first-time preventive treatments for migraine in a primary care setting. If you qualify, you'll receive one of the study medications, and the research team will track how well it reduces your migraine days.
This study tests an oral medication called atogepant to prevent migraines in adults in the UK. It aims to see how well it works when prescribed by a general practitioner in primary care.
This trial tests whether a computer algorithm can help pick the best migraine prevention medicine for you. You'll try one of several common preventives and track your headaches.
This trial compares two medicines taken daily to prevent migraine headaches, with the goal of reducing how often they happen.
This study compares two common medicines, nortriptyline and amitriptyline, to see which works better at preventing migraines. Both are antidepressants that are often used to stop migraines before they start.
This study tests a once-daily pill, atogepant, to see if it safely prevents chronic or episodic migraines in Korean adults. It's meant for people whose doctor has already prescribed the pill for migraine prevention.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.